Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP)
Clinical trial NCT04056195 · COMPLETED
Trial details
- NCT number
- NCT04056195
- Sponsor
- Oscotec Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-11
- Primary completion
- 2023-01-10
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.